Tumor regression and pharmacodynamic (PD) biomarker validation in non-small cell lung cancer (NSCLC) patients treated with the ErbB/VEGFR inhibitor BMS-690514

被引：0
|
作者：
Bahleda, R. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Soria, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Harbison, C. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Park, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Felip, E. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Hanna, N. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Laurie, S. A. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Armand, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Shepherd, F. A. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Herbst, R. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Bristol Myers Squibb, Princeton, NJ USA
[3] Bristol Myers Squibb Co, Princeton, NJ USA
[4] Valle Hebron Univ Hosp, Barcelona, Spain
[5] Indiana Univ, Ctr Canc, Indianapolis, IN 46204 USA
[6] Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada
[7] Inst Claudius Regaud, Toulouse, France
[8] Univ Toronto, Toronto, ON, Canada
[9] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8098
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PRECLINICAL AND CLINICAL ACTIVITY OF BMS-690514 IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC)
    Sbar, E. I.
    Wong, T.
    Salvati, M.
    Pathak, A.
    Mokliatchouk, O.
    Park, J.
    Harbison, C.
    Soria, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 53 - 53
  • [2] A phase I/II multicenter trial of BMS-690514, an ErbB-VEGFR inhibitor, in patients with advanced NSCLC who are erlotinib naive or previously treated with erlotinib
    Soria, J. C.
    Felip, E.
    Herbst, R.
    Hannah, N.
    Laurie, S.
    Armand, J. P.
    Shepherd, F.
    Berman, D.
    EJC SUPPLEMENTS, 2008, 6 (12): : 123 - 123
  • [3] A Double-Blind, Randomized, Parallel, Two-Arm Phase II Trial of BMS-690514 versus Erlotimb in Previous Chemotherapy-Treated Non-Small Cell Lung Cancer (NSCLC) Patients A Safety Review
    Sbar, Eric
    Besse, Benjamin
    Felip, Enriqueta
    Shaw, Alice
    Ahn, Myung-Ju
    Salvati, Mark
    Bhagavatheeswaran, Prabhu
    Soria, Jean-Charles
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S385 - S385
  • [4] A Double-Blind, Randomized, Parallel, Two-Arm Phase H Trial of BMS-690514 versus Erlotinib in Previous Chemotherapy-Treated Non-small Cell Lung Cancer (NSCLC) Patients: A Safety Review
    Sbar, E.
    Besse, B.
    Felip, E.
    Shaw, A.
    Ahn, M.
    Salvati, M.
    Bhagavatheeswaran, P.
    Soria, J.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S538 - S539
  • [5] C-erbB-3 Expression in Non-small Cell Lung Cancer (NSCLC) Patients Treated by Erlotinib
    Cstoth, Ingrid
    Anthoine, Geraldine
    Berghmans, Thierry
    Mascaux, Celine
    Paesmans, Marianne
    Sculier, Jean-Paul
    Meert, Anne-Pascale
    ANTICANCER RESEARCH, 2011, 31 (01) : 281 - 285
  • [6] Tumor hyaluronan (HA) as a novel biomarker in non-small cell lung cancer (NSCLC).
    Gong, Jun
    Guan, Michelle
    Galen, Cook-Wiens
    Larson, Brent K.
    Zhou, Jenny
    Patel, Rishi
    Lapite, Isaac
    Tuli, Richard
    Natale, Ronald B.
    Hendifar, Andrew Eugene
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Biomarker evaluation for PD-1 targeted therapies in non-small cell lung cancer (NSCLC) patients
    Kamphorst, Alice O.
    Pillai, Rathi N.
    Yang, Shu
    Akondy, Rama
    Koenig, Lydia
    Yu, Ke
    McCausland, Megan
    Sica, Gabriel
    Khuri, Fadlo R.
    Owonikoko, Taofeek K.
    Ramalingam, Suresh S.
    Ahmed, Rafi
    CANCER RESEARCH, 2015, 75
  • [8] PD-L1 Immunohistochemistry as Biomarker in Non-Small Cell Lung Cancer (NSCLC)
    Krenbek, Dagmar
    Weidinger, Barbara
    Jarius, Christa
    Holzer, Sophia
    Fabican, Hannah
    Mohn-Staudner, Andrea
    Hochmair, Maximilian
    Chott, Andreas
    Setinekl, Ulrike
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S430 - S430
  • [9] BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation
    Loriot, Y.
    Mordant, P.
    Dorvault, N.
    Rouge, T. De la Motte
    Bourhis, J.
    Soria, J-C
    Deutsch, E.
    BRITISH JOURNAL OF CANCER, 2010, 103 (03) : 347 - 353
  • [10] Tumor regression in non-small cell lung cancer
    Junker, K
    Klinke, V
    Bosse, U
    Thomas, M
    Muller, KM
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 113 - 117
12345